Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-738|1|5221|Hemangiosarcoma (Angiosarcoma), malignant,|Heart,|/ Hemangiosarcoma {malignant}  (Angiosarcoma); Heart Hemangiosarcoma, Heart,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-740|1|5167|Lymphoma, malignant,|Ovary,|/ Lymphoma {malignant}; Ovary Malignant Lymphoma,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-749|1|5582|Inflammation, acute necrotizing,|Adrenal gland,|/ Inflammation, acute necrotizing; Adrenal gland Adrenalitis,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-755|1|4936|Uremia syndrome,Glomerulosclerosis,Status epilepticus,|Kidney,Kidney,Brain,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-766|1|5489|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-775|1|4482|Thrombus,|Lung,|/ Thrombus; Pulmonary artery Pulmonary Thromboembolism,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-785|1|6619|Intervertebral disk syndrome,|Cervical vertebra,|/ Herniated intervertebral disc; Cervical vertebra Luxated Vertebral Disc,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-789|1|5109|Lymphoma, malignant,|Topography, multiple sites,|/ Lymphoma {malignant}; Spleen Malignant Lymphoma,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-792|1|2421|Melanoma, malignant,|Soft palate,|/ Melanoma {malignant}; Soft palate Oral Tumor,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-800|1|6236|Pheochromocytoma, malignant,|Adrenal gland,|/ Pheochromocytoma {malignant}; Adrenal gland Malignant Pheochromocytoma,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-801|1|4508|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-811|1|5572|Melanoma, malignant,|Oral cavity,|/ Melanoma {malignant}; Mouth Oral cav.: Malignant Melanoma,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-846|1|4858|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-861|1|6168|Carcinoma, malignant,Hyperadrenocorticism (Cushings's Disease),|Intestine,Adrenal gland,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-868|1|6253|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-872|1|4650|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right diaphragmatic,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-878|1|5401|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-882|1|4223|Hemangiosarcoma (Angiosarcoma), malignant,|Liver,|/ Hemangiosarcoma {malignant}  (Angiosarcoma); Liver Hemangiosarcoma, Liver,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-885|1|4673|Adenocarcinoma, malignant,Neoplasm, uncertain whether benign or malignant,|Sweat gland,Lung,|,|
1004-3-1|Control,CONTROL|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|lifespan control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-1-903|1|5314|Lymphoma, malignant,|Kidney,|/ Lymphoma {malignant}; Kidney Malignant Lymphoma,|
1004-3-2|Controls, Sacrificed at 8, 9, or 10 years old,CONTROL-SAC|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control|3 (3 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-2-701|2|3684|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology,|
1004-3-2|Controls, Sacrificed at 8, 9, or 10 years old,CONTROL-SAC|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control|3 (3 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-2-703|2|2929|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: Annual Report: Sacrificed,|
1004-3-2|Controls, Sacrificed at 8, 9, or 10 years old,CONTROL-SAC|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control|3 (3 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-2-724|2|3285|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: Annual Report: Sacrificed,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-756|3|5068|Seizure syndrome,|Brain,|/ Seizure (Epileptic episode); Brain Epilepsy,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-770|3|5645|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-788|3|5382|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-807|3|4261|Adenoma, pituitary, with hydrocephalus,Hyperadrenocorticism (Cushings's Disease),|Pituitary gland,Adrenal gland,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-825|3|4732|Hemangiosarcoma (Angiosarcoma), malignant,|Spleen,|/ Hemangioma {benign}; Spleen Hemangiosarcoma, Spleen,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-832|3|5927|Lymphoma, malignant,|Spleen,|/ Lymphoma {malignant}; Spleen Malignant Lymphoma,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-847|3|5514|Uremia syndrome,Renal failure syndrome,|Kidney,Kidney,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-850|3|4908|Osteosarcoma, malignant,Glomerulosclerosis,|Maxilla,Kidney,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-853|3|5463|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Bronchopneumonia,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-858|3|6120|Lymphoid leukemia, malignant,|Blood,|/ Lymphoid leukemia {malignant}; Lymphocytic tissue Lymphocytic Leukemia,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-865|3|6080|Neoplasm, uncertain whether benign or malignant,Inflammation, acute,|Lung,Lung,|,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-867|3|5859|Lymphoma, malignant, w/evidence of metastasis,|Mesenteric lymph node,|/ Lymphoma {malignant}; Mesenteric lymph node Malignant Lymphoma,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-870|3|5199|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Pneumonia,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-875|3|3021|Lymphoma, malignant,|Kidney,|/ Lymphoma {malignant}; Kidney Kidney: Malignant Lymphoma,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-879|3|5222|Hemangiosarcoma (Angiosarcoma), malignant,|Liver,|/ Hemangiosarcoma {malignant}  (Angiosarcoma); Liver Hemangiosarcoma, Liver,Spleen,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-886|3|5084|Meningioma, malignant,|Brain,|/ Meningioma {malignant}; Brain Meningioma, Malignant,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-891|3|4003|Sepsis,|Prostate,|/ Sepsis; Prostate,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-899|3|3913|Hemangiosarcoma (Angiosarcoma), malignant,|Heart,|/ Hemangiosarcoma {malignant}  (Angiosarcoma); Spleen Hemangiosarcoma, Heart,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-900|3|4331|Sarcoma, undifferentiated, malignant,Plasma cell myeloma, malignant,|n/a|Round Cell Sarcoma / Plasma cell myeloma {malignant}; Subcutaneous tissue Round Cell Sarcoma / ,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-904|3|4906|Chondrosarcoma, malignant,|Nasal cavity,|/ Chondrosarcoma {malignant}; Nose Chondrosarcoma, Nasal,|
1004-3-3|0.0003 uCi/kg Initial Body Burden,LOWEST 0.0111 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-3-907|3|5779|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Pneumonia,|
1004-3-4|0.0003 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.011 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-4-762|4|2784|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology,|
1004-3-4|0.0003 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.011 kBq/g|1|400|Pu-239 dioxide|0.0111|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-4-849|4|1033|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-748|5|4460|Transitional cell carcinoma, malignant,|Topography, multiple sites,|Undetermined manner of death / Cause of death undetermined; Topography unknown Unknown Cause,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-754|5|3141|Seizure syndrome,|Brain,|/ Seizure (Epileptic episode); Brain Epilepsy,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-757|5|6383|Leiomyosarcoma, malignant,Neoplasm, uncertain whether benign or malignant,|Kidney,Lung,|,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-767|5|6020|Heart failure, (Congestive),Valvular heart disease or syndrome,|Heart,Heart,|,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-769|5|3294|Granulosa cell tumor, benign,|Ovary,|/ Granulosa cell tumor {malignant}; Ovary Ovarian Tumor,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-776|5|5562|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Bronchopneumonia,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-780|5|4652|Pheochromocytoma, malignant,|Adrenal gland,|/ Pheochromocytoma {malignant}; Adrenal gland Pheochromocytoma,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-806|5|4723|Melanoma, malignant,|Soft palate,|/ Melanoma {malignant}; Soft palate Palate: Malignant Melanoma,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-813|5|5128|Sarcoma, malignant,|Cranial and facial bone,|/ Sarcoma {malignant}; Cranial and facial bone Multilobular Sarcoma, Skull,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-826|5|5249|Hemangiosarcoma (Angiosarcoma), malignant,|Spleen,|/ Hemangioma {benign}; Spleen Hemangioma, Spleen,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-831|5|5269|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Pneumonia,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-841|5|5950|Lymphoma, malignant,|Mesenteric lymph node,|/ Lymphoma {malignant}; Mesenteric lymph node Malignant Lymphoma,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-842|5|5615|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left apical,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left apical,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-845|5|5347|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional cell carcinoma {malignant}; Urinary bladder Urinary Bladder Tumor,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-859|5|5228|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional cell carcinoma {malignant}; Urinary bladder Urinary Bladder Tumor,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-862|5|4926|Inflammation, acute,|Abdomen, peritoneum and retroperitoneum,|/ Inflammation, acute; Abdomen, peritoneum and retroperitoneum Peritonitis,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-871|5|6010|Melanoma, malignant,|Oral cavity,|/ Melanoma {malignant}; Mouth Malignant Melanoma, Oral,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-874|5|5536|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-876|5|5869|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-881|5|6093|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Acute Pneumonia,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-893|5|5834|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Pneumonia,|
1004-3-5|0.0020 uCi/kg Initial Body Burden,LOW 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-5-908|5|3549|Transitional cell carcinoma, malignant,|Topography, multiple sites,|Undetermined manner of death / Cause of death undetermined; Topography unknown Unknown, Pulmon. Hyalinosis,|
1004-3-6|0.0020 uCi/kg Initial Body Burden, SACRIFICED,LOW-SAC 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-6-798|6|1773|Normal tissue morphology,|Topography, multiple sites,|/ Scheduled sacrifice, no significant pathology,|
1004-3-6|0.0020 uCi/kg Initial Body Burden, SACRIFICED,LOW-SAC 0.074 kBqkg|1|400|Pu-239 dioxide|0.074|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-6-920|6|515|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-697|7|4071|Heart failure, (Congestive),Valvular heart disease or syndrome,|Heart,Heart,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-750|7|5504|Lymphoma, malignant,Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right intermediate,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right intermediate Lung Tmr, Malignant Lymphoma / ,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-752|7|3551|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left cardiac,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left cardiac Lung Tumor, Adrenal Tumor,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-771|7|5252|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-778|7|3711|Thrombus,|Lung,|/ Thrombus; Lung Pulmonary Thromboembolism,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-781|7|4240|Hemangiosarcoma (Angiosarcoma), malignant,Neoplasm, uncertain whether benign or malignant,|Kidney,Lung,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-782|7|5066|Neurofibrosarcoma, malignant,|Branchial arch,|/ Neurofibrosarcoma {malignant}; Brachial plexus, NOS Neurofibrosarcoma,Brach.Pl.,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-786|7|6158|Carcinoma, malignant,Neoplasm, uncertain whether benign or malignant,|Adrenal cortex,Lung,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-795|7|5068|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-797|7|6051|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right diaphragmatic,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-802|7|5547|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Pneumonia,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-823|7|5289|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional cell carcinoma {malignant}; Urethra Urinary Bladder Tumor,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-827|7|5513|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis; Lung Acute Pneumonitis,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-834|7|3492|Pyometra,|Uterus,|/ Pyometra; Uterus,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-838|7|5334|Lymphoma, malignant,|Small intestine,|/ Lymphoma {malignant}; Small intestine Malignant Lymphoma, Lung Tmr,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-844|7|5711|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-848|7|6122|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Acute Pneumonia,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-851|7|6188|Carcinoma, malignant,Hypothyroidism,|Thyroid gland,Thyroid gland,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-877|7|5870|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right diaphragmatic,|/ Squamous cell carcinoma {malignant} (epidermoid carcinoma); Lung Lobe, right diaphragmatic,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-883|7|6494|Uremia syndrome,Glomerulosclerosis,|Kidney,Kidney,|,|
1004-3-7|0.007 uCi/kg Initial Body Burden,MED-LOW 0.259 kBq/kg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-7-884|7|5264|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right diaphragmatic,|/ Squamous cell carcinoma {malignant} (epidermoid carcinoma); Lung Lobe, right diaphragmatic,|
1004-3-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC 0.259 0.074 kBqkg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-8-815|8|1269|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology,|
1004-3-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC 0.259 0.074 kBqkg|1|400|Pu-239 dioxide|0.259|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-8-918|8|514|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-764|9|4769|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-777|9|3924|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-787|9|3491|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-794|9|4177|Adenoma, pituitary, with hydrocephalus,Hyperadrenocorticism (Cushings's Disease),|Pituitary gland,Adrenal gland,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-803|9|2942|Inflammation, diffuse, interstitial,|Lung,|/ Inflammation, pneumonitis; Lung Interstitial Pneumonitis,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-805|9|4624|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,Neoplastic disease, uncertain whether benign or malignant,|Lung Lobe, right cardiac,Esophagus,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-808|9|4673|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right diaphragmatic,|Papillary / Papillary adenocarcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-809|9|4204|Cirrhosis,Adrenocortical insufficiency syndrome, chronic (Addison's di,|Liver,Adrenal gland,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-810|9|4308|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-812|9|3641|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, right apical,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-814|9|3608|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,Adenoma, benign,|Lung Lobe, right diaphragmatic,Thyroid gland,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-819|9|5742|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,Disease or syndrome present,|Lung Lobe, left diaphragmatic,Kidney,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-824|9|4072|Inflammation, acute,|Lung,|/ Inflammation, acute, bronchopneumonia; Lung Bronchopneumonia,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-833|9|4863|Neoplasm, uncertain whether benign or malignant,Tumor, (growth),Inflammation,Pyometra,|Adrenal gland,Thyroid gland,Uterus,Uterus,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-835|9|3117|Reticulosarcoma (Histocytic Lymphosarcoma), malignant,|n/a|/ Reticulosarcoma {malignant}  (Histocytic Lymphosarcoma); Lymphocytic tissue Reticulum Cell Sarcoma,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-836|9|4112|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-839|9|5893|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,Hepatocellular carcinoma, malignant,|Lung Lobe, left diaphragmatic,Biliary tract,|,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-854|9|4411|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-857|9|3837|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-860|9|4560|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right diaphragmatic,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-866|9|5269|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right intermediate Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-888|9|3346|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right intermediate,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right intermediate Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-892|9|4125|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left cardiac,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left cardiac Lung Tumor,|
1004-3-9|0.026 uCi/kg Initial Body Burden,MEDIUM 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|24 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-9-905|9|4591|Lymphoma, malignant,|Small intestine,|/ Lymphoma {malignant}; Small intestine Malignant Lymphoma,|
1004-3-10|0.026 uCi/kg Initial Body Burden, SACRIFICED,MEDIUM-SAC 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-10-478|10|1956|n/a|n/a|n/a|
1004-3-10|0.026 uCi/kg Initial Body Burden, SACRIFICED,MEDIUM-SAC 0.962 kBq/kg|1|400|Pu-239 dioxide|0.962|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-10-816|10|527|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: PNL Death Type: KNOWN,  PI's findings: Sacrificed, (PNL study: CHRONIC EFFECTS OF INHALED LOW LEVEL 239PU),|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-727|11|2778|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left cardiac,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left cardiac Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-759|11|2182|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left apical Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-760|11|1526|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-761|11|2701|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, right diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-772|11|2201|Bronchiolo-alveolar adenocarcinoma, malignant,Osteoarthropathy, hypertrophic,|Lung Lobe, left apical,Humerus,|,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-783|11|2334|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right cardiac,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right cardiac Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-796|11|2157|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, left diaphragmatic,|/ Squamous cell carcinoma {malignant} (epidermoid carcinoma); Lung Lobe, left diaphragmatic,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-804|11|1762|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, right cardiac,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, right cardiac,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-820|11|3470|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-837|11|2778|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-840|11|3787|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, right cardiac,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right cardiac Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-852|11|2978|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-856|11|3411|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, right apical Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-863|11|2828|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, left apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, left apical Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-864|11|3570|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left diaphragmatic,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-873|11|2396|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left cardiac,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left cardiac Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-880|11|3155|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right diaphragmatic,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right diaphragmatic Lung Tumor,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-889|11|3358|Squamous cell carcinoma, malignant (epidermoid carcinoma),|Lung Lobe, right apical,|/ Adenosquamous carcinoma {malignant}; Lung Lobe, right apical Lung Tumor, Osteoarthropathy,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-898|11|3859|Transitional cell carcinoma, malignant,Neoplasm, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Urinary bladder transitional epithelium,Lung,Adrenal gland,|,|
1004-3-11|0.09 uCi/kg Initial Body Burden,MED-HIGH 3,33 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-11-909|11|3978|Adenocarcinoma, simple, papillary (AFIP 80822), malignant,|Lung Lobe, left apical,|/ Papillary adenocarcinoma {malignant}; Lung Lobe, left apical Lung Tumor,|
1004-3-12|0.09 uCi/kg Initial Body Burden, SACRIFICED,MED-HIGH-SAC 33.3 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-12-702|12|744|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: PNL Death Type: SACRIFI,  PI's findings: Sacrificed, (PNL study: CHRONIC EFFECTS OF INHALED LOW LEVEL 239PU),|
1004-3-12|0.09 uCi/kg Initial Body Burden, SACRIFICED,MED-HIGH-SAC 33.3 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-12-709|12|737|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: PNL Death Type: SACRIFI,  PI's findings: Sacrificed, (PNL study: CHRONIC EFFECTS OF INHALED LOW LEVEL 239PU),|
1004-3-12|0.09 uCi/kg Initial Body Burden, SACRIFICED,MED-HIGH-SAC 33.3 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-12-734|12|727|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: PNL Death Type: SACRIFI,  PI's findings: Sacrificed, (PNL study: CHRONIC EFFECTS OF INHALED LOW LEVEL 239PU),|
1004-3-12|0.09 uCi/kg Initial Body Burden, SACRIFICED,MED-HIGH-SAC 33.3 0.074 kBqkg|1|400|Pu-239 dioxide|3.33|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-12-739|12|706|Normal tissue morphology,|Topography, multiple sites,|Scheduled sacrifice, no significant pathology / Scheduled sacrifice, no significant pathology; old info: PNL Death Type: SACRIFI,  PI's findings: Sacrificed, (PNL study: CHRONIC EFFECTS OF INHALED LOW LEVEL 239PU),|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-747|13|954|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-753|13|2676|Bronchiolo-alveolar adenocarcinoma, malignant,|Lung Lobe, left diaphragmatic,|/ Bronchiolo-alveolar adenocarcinoma {malignant}; Lung Lobe, left diaphragmatic Lung Tumor,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-817|13|1212|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-829|13|1380|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-890|13|1433|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-896|13|946|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-906|13|862|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-13|0.60 uCi/kg Initial Body Burden,HIGH 22.2 kBqkg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-13-910|13|821|Inflammation, pneumonitis, radiation induced,|Lung,|/ Inflammation, pneumonitis, radiation induced; Lung Radiation Pneumonitis,|
1004-3-14|0.60 uCi/kg Initial Body Burden, SACRIFICED,HIGH-SAC 22.2 kBq/kg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-14-435|14|2305|n/a|n/a|n/a|
1004-3-14|0.60 uCi/kg Initial Body Burden, SACRIFICED,HIGH-SAC 22.2 kBq/kg|1|400|Pu-239 dioxide|22.2|kilobecquerels per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|2 (2 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-3-14-913|14|561|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-479|99|1967|n/a|n/a|n/a|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-698|99|666|Normal tissue morphology,|Topography, multiple sites,|/  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-735|99|640|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-741|99|615|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-742|99|615|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-743|99|615|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-744|99|590|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-2033|99|310|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
1004-3-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|1004-3-99-2036|99|280|Normal tissue morphology,|Topography, multiple sites,|no significant pathology /  no significant pathology,|
